homevideos Newshealthcare NewsCOVID Vaccine: SEC seeks more information from Serum Institute and Bharat Biotech
COVID Vaccine: SEC seeks more information from Serum Institute and Bharat Biotech
While UK has approved Astrazeneca vaccine, Indian government's nod for the vaccine may take some more time. The expert panel on vaccine is believed to have sought more information from Serum Institute, which is the India partner and has submitted an application for the vaccine dubbed "Covishield" in India.
While UK has approved Astrazeneca vaccine, Indian government's nod for the vaccine may take some more time. The expert panel on vaccine is believed to have sought more information from Serum Institute, which is the India partner and has submitted an application for the vaccine dubbed "Covishield" in India.
Timsy Jaipuria reports that applications of both Bharat Biotech and Serum Institute were not considered for Emergency Use Authorization (EUA) today by the subject expert committee (SEC).
Jaipuria said SEC has sought more information on well-updated factsheets, prescribing information and additional information from Serum Institute, while Bharat Biotech has been asked to submit more data.
Watch video for more.
(Edited by : Bivekanda Biswas)
First Published: Dec 30, 2020 8:48 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
BJP is planning to ban RSS, says Shiv Sena (UBT) chief Uddhav Thackeray
May 18, 2024 8:01 PM
Punjab Lok Sabha elections: Complete list of Congress candidates
May 18, 2024 4:08 PM
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM